Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome

•Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS.•Targeting bacteria, their toxins, and downstream signaling pathways in malignant T cells abrogate the induction of drug resistance. [Display omitted] Patients with Sézary syndrome (SS), a leukemic variant...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 143; no. 15; pp. 1496 - 1512
Main Authors Vadivel, Chella Krishna, Willerslev-Olsen, Andreas, Namini, Martin R. J., Zeng, Ziao, Yan, Lang, Danielsen, Maria, Gluud, Maria, Pallesen, Emil M. H., Wojewoda, Karolina, Osmancevic, Amra, Hedebo, Signe, Chang, Yun-Tsan, Lindahl, Lise M., Koralov, Sergei B., Geskin, Larisa J., Bates, Susan E., Iversen, Lars, Litman, Thomas, Bech, Rikke, Wobser, Marion, Guenova, Emmanuella, Kamstrup, Maria R., Ødum, Niels, Buus, Terkild B.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 11.04.2024
The American Society of Hematology
Subjects
Lymphoid Neoplasia
Online AccessGet full text

Cover

Abstract •Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS.•Targeting bacteria, their toxins, and downstream signaling pathways in malignant T cells abrogate the induction of drug resistance. [Display omitted] Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus–specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus. Patients with Sézary syndrome (SS) are prone to Staphylococcus aureus infections and have treatment resistance which leads to poor prognosis. Vadivel and colleagues link these observations, suggesting that staphylococcal enterotoxins (SE) induce drug resistance in SS T cells through induction of several T-cell signaling pathways. Treatment with antibacterials as well as downstream mediators triggered by SE abrogate drug resistance, suggesting that antistaphylococcal antibiotics might improve outcomes of SS-directed therapy.
AbstractList Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus-specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.
• Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS. • Targeting bacteria, their toxins, and downstream signaling pathways in malignant T cells abrogate the induction of drug resistance. Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus –specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus . Patients with Sézary syndrome (SS) are prone to Staphylococcus aureus infections and have treatment resistance which leads to poor prognosis. Vadivel and colleagues link these observations, suggesting that staphylococcal enterotoxins (SE) induce drug resistance in SS T cells through induction of several T-cell signaling pathways. Treatment with antibacterials as well as downstream mediators triggered by SE abrogate drug resistance, suggesting that antistaphylococcal antibiotics might improve outcomes of SS-directed therapy.
Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus-specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.ABSTRACTPatients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus-specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.
•Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS.•Targeting bacteria, their toxins, and downstream signaling pathways in malignant T cells abrogate the induction of drug resistance. [Display omitted] Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus–specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus. Patients with Sézary syndrome (SS) are prone to Staphylococcus aureus infections and have treatment resistance which leads to poor prognosis. Vadivel and colleagues link these observations, suggesting that staphylococcal enterotoxins (SE) induce drug resistance in SS T cells through induction of several T-cell signaling pathways. Treatment with antibacterials as well as downstream mediators triggered by SE abrogate drug resistance, suggesting that antistaphylococcal antibiotics might improve outcomes of SS-directed therapy.
Abstract Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor prognosis due to treatment resistance. Here, we report that S aureus and staphylococcal enterotoxins (SE) induce drug resistance in malignant T cells against therapeutics commonly used in CTCL. Supernatant from patient-derived, SE-producing S aureus and recombinant SE significantly inhibit cell death induced by histone deacetylase (HDAC) inhibitor romidepsin in primary malignant T cells from patients with SS. Bacterial killing by engineered, bacteriophage-derived, S aureus–specific endolysin (XZ.700) abrogates the effect of S aureus supernatant. Similarly, mutations in major histocompatibility complex (MHC) class II binding sites of SE type A (SEA) and anti-SEA antibody block induction of resistance. Importantly, SE also triggers resistance to other HDAC inhibitors (vorinostat and resminostat) and chemotherapeutic drugs (doxorubicin and etoposide). Multimodal single-cell sequencing indicates T-cell receptor (TCR), NF-κB, and JAK/STAT signaling pathways (previously associated with drug resistance) as putative mediators of SE-induced drug resistance. In support, inhibition of TCR-signaling and Protein kinase C (upstream of NF-κB) counteracts SE-induced rescue from drug-induced cell death. Inversely, SE cannot rescue from cell death induced by the proteasome/NF-κB inhibitor bortezomib. Inhibition of JAK/STAT only blocks rescue in patients whose malignant T-cell survival is dependent on SE-induced cytokines, suggesting 2 distinct ways SE can induce drug resistance. In conclusion, we show that S aureus enterotoxins induce drug resistance in primary malignant T cells. These findings suggest that S aureus enterotoxins cause clinical treatment resistance in patients with SS, and antibacterial measures may improve the outcome of cancer-directed therapy in patients harboring S aureus.
Author Iversen, Lars
Lindahl, Lise M.
Koralov, Sergei B.
Willerslev-Olsen, Andreas
Zeng, Ziao
Gluud, Maria
Osmancevic, Amra
Hedebo, Signe
Yan, Lang
Ødum, Niels
Geskin, Larisa J.
Danielsen, Maria
Bech, Rikke
Kamstrup, Maria R.
Litman, Thomas
Guenova, Emmanuella
Pallesen, Emil M. H.
Bates, Susan E.
Wobser, Marion
Buus, Terkild B.
Vadivel, Chella Krishna
Chang, Yun-Tsan
Namini, Martin R. J.
Wojewoda, Karolina
Author_xml – sequence: 1
  givenname: Chella Krishna
  orcidid: 0000-0002-3710-5143
  surname: Vadivel
  fullname: Vadivel, Chella Krishna
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 2
  givenname: Andreas
  orcidid: 0000-0001-9687-7269
  surname: Willerslev-Olsen
  fullname: Willerslev-Olsen, Andreas
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 3
  givenname: Martin R. J.
  orcidid: 0000-0001-7526-7883
  surname: Namini
  fullname: Namini, Martin R. J.
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 4
  givenname: Ziao
  orcidid: 0000-0002-9138-602X
  surname: Zeng
  fullname: Zeng, Ziao
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 5
  givenname: Lang
  surname: Yan
  fullname: Yan, Lang
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 6
  givenname: Maria
  orcidid: 0000-0002-8661-2256
  surname: Danielsen
  fullname: Danielsen, Maria
  organization: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 7
  givenname: Maria
  surname: Gluud
  fullname: Gluud, Maria
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 8
  givenname: Emil M. H.
  surname: Pallesen
  fullname: Pallesen, Emil M. H.
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 9
  givenname: Karolina
  orcidid: 0000-0002-3494-5155
  surname: Wojewoda
  fullname: Wojewoda, Karolina
  organization: Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
– sequence: 10
  givenname: Amra
  orcidid: 0000-0002-8227-8369
  surname: Osmancevic
  fullname: Osmancevic, Amra
  organization: Department of Dermatology and Venereology, Region Västra Götaland, Sahlgrenska University Hospital, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
– sequence: 11
  givenname: Signe
  orcidid: 0009-0006-2481-035X
  surname: Hedebo
  fullname: Hedebo, Signe
  organization: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 12
  givenname: Yun-Tsan
  orcidid: 0000-0001-6081-9614
  surname: Chang
  fullname: Chang, Yun-Tsan
  organization: Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
– sequence: 13
  givenname: Lise M.
  surname: Lindahl
  fullname: Lindahl, Lise M.
  organization: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 14
  givenname: Sergei B.
  orcidid: 0000-0002-4843-3791
  surname: Koralov
  fullname: Koralov, Sergei B.
  organization: Department of Pathology, New York University School of Medicine, New York, NY
– sequence: 15
  givenname: Larisa J.
  surname: Geskin
  fullname: Geskin, Larisa J.
  organization: Department of Dermatology, Columbia University Irving Medical Center, New York, NY
– sequence: 16
  givenname: Susan E.
  orcidid: 0000-0001-6708-0330
  surname: Bates
  fullname: Bates, Susan E.
  organization: Division of Hematology/Oncology, Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY
– sequence: 17
  givenname: Lars
  surname: Iversen
  fullname: Iversen, Lars
  organization: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 18
  givenname: Thomas
  orcidid: 0000-0002-6068-901X
  surname: Litman
  fullname: Litman, Thomas
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 19
  givenname: Rikke
  surname: Bech
  fullname: Bech, Rikke
  organization: Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark
– sequence: 20
  givenname: Marion
  orcidid: 0000-0002-6293-2554
  surname: Wobser
  fullname: Wobser, Marion
  organization: Department of Dermatology, University Hospital Würzburg, Würzburg, Germany
– sequence: 21
  givenname: Emmanuella
  orcidid: 0000-0001-5478-8735
  surname: Guenova
  fullname: Guenova, Emmanuella
  organization: Department of Dermatology and Venereology, University Hospital Centre (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
– sequence: 22
  givenname: Maria R.
  orcidid: 0000-0003-2173-4516
  surname: Kamstrup
  fullname: Kamstrup, Maria R.
  organization: Department of Dermatology, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark
– sequence: 23
  givenname: Niels
  orcidid: 0000-0003-3135-5624
  surname: Ødum
  fullname: Ødum, Niels
  email: ndum@sund.ku.dk
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
– sequence: 24
  givenname: Terkild B.
  orcidid: 0000-0001-7180-6384
  surname: Buus
  fullname: Buus, Terkild B.
  email: terkild.buus@sund.ku.dk
  organization: LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38170178$$D View this record in MEDLINE/PubMed
BookMark eNp1UT1vFDEQtVAQuRz0VGhLmg0z9n6ZBqGIAFIkihy15R3PJUZ768PejXT5NbT8DfLH8HEhQEE1o_GbN8_vnYijMYwsxHOEU8ROvuqHENypBKlAYtPiI7HAWnYlgIQjsQCApqx0i8fiJKUvAFgpWT8Rx6rDFrDtFmJ1Odnt9W4IFIjmVNg5ci5-dDNxKlycr4rIyafJjsR5_uMb7btYrAriYdhDi8u777c27oq0G10MG34qHq_tkPjZfV2Kz-fvVmcfyotP7z-evb0oqaq6qeypaaTGGnTfVLW06FCBIm2BemwlayRUhJVrXN9J3XIttbZ1r0k5t14rtRRvDrzbud-wIx6naAezjX6T5Zhgvfn3ZfTX5ircGERQqsluLMXLe4YYvs6cJrPxaf8vO3KYk8nyADstZZ2hcIBSDClFXj_cQTD7NMyvNMyfNPLKi7_1PSz8tj8DXh8AnF268RxNIs_ZXucj02Rc8P9n_wldR57B
CitedBy_id crossref_primary_10_1016_j_imlet_2024_106871
crossref_primary_10_1016_j_jid_2024_03_022
crossref_primary_10_3390_cancers16111948
crossref_primary_10_3389_fimmu_2024_1255859
crossref_primary_10_1182_blood_2023023690
crossref_primary_10_1016_j_jid_2024_04_018
crossref_primary_10_3390_cells13060503
Cites_doi 10.1158/2159-8290.CD-21-1207
10.1158/1078-0432.CCR-16-3185
10.1016/j.it.2013.02.002
10.1182/blood.V89.1.32.32_32_40
10.3390/toxins5081402
10.1038/s41408-020-0324-3
10.1016/j.cyto.2018.03.041
10.1182/blood-2014-01-551184
10.1182/blood-2006-04-017863
10.1111/j.1365-2133.2005.06524.x
10.1084/jem.182.5.1573
10.1182/blood.2019002236
10.1016/j.jid.2023.06.205
10.1016/j.jid.2023.01.039
10.1158/0008-5472.CAN-07-6091
10.1016/j.jid.2019.03.1130
10.1056/NEJM197308162890703
10.1158/1078-0432.CCR-19-0148
10.1016/j.jid.2019.07.693
10.1182/blood.2019004256
10.1158/1078-0432.CCR-14-0077
10.1038/s41572-021-00296-9
10.1080/08927014.2021.1887151
10.1200/JCO.2006.10.2434
10.1016/0002-9343(81)90107-8
10.1002/gcc.22679
10.1038/cddis.2010.16
10.1016/j.xjidi.2022.100132
10.1002/cncr.10829
10.1001/archderm.139.7.857
10.1002/ajh.20732
10.1158/1078-0432.CCR-18-3309
10.1016/j.jaad.2009.11.692
10.1016/j.molonc.2014.05.001
10.1182/blood.2020009346
10.1080/10428194.2020.1779259
10.4161/15384101.2014.965061
10.15252/emmm.202115200
10.1016/j.tibs.2017.11.008
10.1016/j.yexmp.2010.05.001
10.1182/blood-2015-08-662353
10.1111/1523-1747.ep12494184
10.1016/j.jid.2021.04.023
10.1182/blood-2005-06-2536
10.1182/blood-2014-05-571778
10.1158/1078-0432.CCR-07-2114
10.1111/j.1365-2133.2008.08612.x
10.1046/j.1523-1747.2001.01456.x
10.3390/cancers13020280
10.1111/dth.12586
10.1038/ng.3356
10.1182/blood-2014-11-611194
10.1001/jamadermatol.2018.2756
10.1016/j.molmed.2007.09.002
10.1016/j.canlet.2015.01.021
10.1016/j.xjidi.2021.100084
10.1182/blood.2018888107
10.1073/pnas.93.17.9148
10.5070/D33BS957XS
10.1182/blood-2007-04-084814
10.7326/0003-4819-83-4-534
10.1182/blood.2022016690
10.7554/eLife.61973
10.1016/j.jdcr.2020.05.035
10.1016/j.cbi.2021.109450
10.1002/cncr.11593
10.1056/NEJMra032810
10.1128/aac.02273-21
10.4161/cbt.12.12.18144
10.3389/fcimb.2022.850509
10.1111/j.1365-2133.1995.tb02485.x
10.1182/bloodadvances.2018022608
10.1200/JCO.2007.11.4207
10.1001/jama.1992.03480100060031
10.1073/pnas.94.13.6764
10.1074/jbc.M007732200
10.1016/j.jid.2021.01.038
10.1182/blood-2012-08-449140
10.1016/j.jaad.2020.12.026
10.1007/s12026-011-8216-z
10.1038/jid.2014.284
10.1309/U1Y6-J4AG-5M4M-7AYV
10.1016/j.jid.2023.08.031
ContentType Journal Article
Copyright 2024 American Society of Hematology
2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology
Copyright_xml – notice: 2024 American Society of Hematology
– notice: 2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
– notice: 2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. 2024 American Society of Hematology
DBID 6I.
AAFTH
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1182/blood.2023021671
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList PubMed

MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
EndPage 1512
ExternalDocumentID 10_1182_blood_2023021671
38170178
S0006497124000314
Genre Journal Article
GroupedDBID ---
-~X
.55
0R~
1CY
23N
2WC
34G
39C
4.4
53G
5GY
5RE
6I.
6J9
AAEDW
AAFTH
AAXUO
ABOCM
ACGFO
ADBBV
AENEX
AFOSN
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BTFSW
CS3
DIK
DU5
E3Z
EBS
EJD
EX3
F5P
FDB
FRP
GS5
GX1
IH2
K-O
KQ8
L7B
LSO
MJL
N9A
OK1
P2P
R.V
RHF
RHI
ROL
SJN
THE
TR2
TWZ
W2D
WH7
WOQ
WOW
X7M
YHG
YKV
ZA5
AALRI
AFETI
AITUG
NPM
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c448t-bc66291509b6452a1d1303c9a0cb172e91c13c14d6db8297e5299a5b9c3ddff33
ISSN 0006-4971
1528-0020
IngestDate Tue Sep 17 21:28:21 EDT 2024
Sat Nov 02 16:45:10 EDT 2024
Wed Nov 13 12:48:58 EST 2024
Sat Nov 02 12:29:49 EDT 2024
Sat Apr 13 16:36:02 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 15
Language English
License This is an open access article under the CC BY-NC-ND license.
2024 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c448t-bc66291509b6452a1d1303c9a0cb172e91c13c14d6db8297e5299a5b9c3ddff33
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0009-0006-2481-035X
0000-0001-9687-7269
0000-0002-8227-8369
0000-0003-2173-4516
0000-0001-7180-6384
0000-0002-4843-3791
0000-0001-7526-7883
0000-0001-5478-8735
0000-0002-6293-2554
0000-0001-6081-9614
0000-0002-6068-901X
0000-0002-3494-5155
0000-0002-3710-5143
0000-0002-9138-602X
0000-0001-6708-0330
0000-0002-8661-2256
0000-0003-3135-5624
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC11033614
PMID 38170178
PQID 2910189225
PQPubID 23479
PageCount 17
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_11033614
proquest_miscellaneous_2910189225
crossref_primary_10_1182_blood_2023021671
pubmed_primary_38170178
elsevier_sciencedirect_doi_10_1182_blood_2023021671
PublicationCentury 2000
PublicationDate 2024-04-11
PublicationDateYYYYMMDD 2024-04-11
PublicationDate_xml – month: 04
  year: 2024
  text: 2024-04-11
  day: 11
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 2024
Publisher Elsevier Inc
The American Society of Hematology
Publisher_xml – name: Elsevier Inc
– name: The American Society of Hematology
References Hooper, LeWitt, Veon (bib22) 2022; 2
Chiao, Na, Niu, Sclabas, Dong, Curley (bib74) 2002; 95
Liu, Sun, Gao (bib88) 2024; 144
Jones, Dang, Duvic, Washington, Huh (bib48) 2001; 115
Huang, Su, Jiang, Zhou (bib45) 2015; 125
Song, Chang, Seminario-Vidal (bib10) 2022; 12
Thode, Woetmann, Wandall (bib29) 2015; 135
Zhang, Seminario-Vidal, Cohen (bib21) 2022; 12
Tokura, Yagi, Ohshima (bib32) 1995; 133
Cheng, Montecalvo, Kane (bib79) 2011; 50
Fantin, Richon (bib73) 2007; 13
Westergaard, Lechowicz, Harrington, Elsey, Arbiser, Khan (bib54) 2020; 6
Gaydosik, Tabib, Geskin (bib67) 2019; 25
Zinzani, Musuraca, Tani (bib53) 2007; 25
Choi, Goh, Walradt (bib7) 2015; 47
Bastidas Torres, Cats, Mei (bib8) 2018; 57
Gluud, Pallesen, Buus (bib28) 2023; 141
Abraham, Zhang, Odum, Wasik (bib80) 2011; 12
Mirvish, Pomerantz, Geskin (bib20) 2011; 64
Pallesen, Gluud, Vadivel (bib38) 2023; 143
Herrera, Cheng, Mimitou (bib44) 2021; 138
Willerslev-Olsen, Krejsgaard, Lindahl (bib26) 2013; 5
Hurabielle, Thonnart, Ram-Wolff (bib46) 2017; 23
Willerslev-Olsen, Buus, Nastasi (bib70) 2020; 10
Vonderheid, Bigler, Hou (bib82) 2005; 152
Allen, Switchenko, Ayers, Kim, Lechowicz (bib23) 2020; 61
Lindahl, Willerslev-Olsen, Gjerdrum (bib35) 2019; 134
Sorger, Dey, Vieyra-Garcia (bib18) 2022; 14
Luchenko, Litman, Chakraborty (bib37) 2014; 8
Hammarén, Virtanen, Raivola, Silvennoinen (bib63) 2019; 118
Kim, Liu, Mraz-Gernhard, Varghese, Hoppe (bib6) 2003; 139
Abdin, Tolba, Zaher, Omar (bib75) 2021; 340
Tokura, Heald, Yan, Edelson (bib81) 1992; 98
Suga, Sugaya, Miyagaki (bib30) 2014; 20
Vermeer (bib87) 2019; 134
Willerslev-Olsen, Gjerdrum, Lindahl (bib69) 2021; 141
Lu, Fang, Feng (bib83) 2015; 359
Tensen, Quint, Vermeer (bib11) 2022; 139
Zhang, Nowak, Vonderheid (bib16) 1996; 93
Talpur, Bassett, Duvic (bib34) 2008; 159
bib50
Willerslev-Olsen, Krejsgaard, Lindahl (bib71) 2016; 127
Mehindate, Thibodeau, Dohlsten, Kalland, Sékaly, Mourad (bib43) 1995; 182
Olsen, Kim, Kuzel (bib49) 2007; 25
Butler, McKenzie, Jones (bib86) 2019; 139
Morotti, Cilloni, Pautasso (bib76) 2006; 81
McGirt, Jia, Baerenwald (bib9) 2015; 126
Girardi, Heald, Wilson (bib5) 2004; 350
Dehner, Ruff, Greiling (bib27) 2022; 2
Chang, Vancurova (bib56) 2013; 3
Vonderheid, Bigler, Kotecha (bib47) 2001; 117
Dummer, Vermeer, Scarisbrick (bib3) 2021; 7
Bonin, Tothova, Barbazza, Brunetti, Stanta, Trevisan (bib25) 2010; 89
Vadivel, Gluud, Torres-Rusillo (bib41) 2021; 13
Buus, Willerslev-Olsen, Fredholm (bib66) 2018; 2
Buus, Herrera, Ivanova (bib42) 2021; 10
Weiner, Durgin, Wysocka, Rook (bib12) 2021; 84
Krejsgaard, Willerslev-Olsen, Lindahl (bib72) 2014; 124
Lutzner, Edelson, Schein, Green, Kirkpatrick, Ahmed (bib4) 1975; 83
Axelrod, Lorber, Vonderheid (bib19) 1992; 267
Guenova, Ødum (bib89) 2024; 144
Kawai, Akira (bib62) 2007; 13
Meley, Spiller, White, McDowell, Pizer, See (bib77) 2010; 1
Wu, Wood (bib55) 2018; 154
Eichenseher, Herpers, Badoux (bib39) 2022; 66
Nielsen, Kaltoft, Nordahl (bib17) 1997; 94
Paul, Schaefer (bib57) 2013; 34
bib60
Cortes, Patrone, Quinn (bib85) 2021; 141
Woetmann, Lovato, Eriksen (bib68) 2007; 109
Courtney, Lo, Weiss (bib58) 2018; 43
Patel, Flanagan, Martins (bib13) 2020; 140
Wollina, Dummer, Brockmeyer (bib51) 2003; 98
Meyer, Jesson, Li (bib64) 2010; 7
Sézary, Bouvrain (bib1) 1938; 45
Jackow, Cather, Hearne, Asano, Musser, Duvic (bib31) 1997; 89
Emge, Bassett, Duvic, Huen (bib33) 2019; 81
Netchiporouk, Litvinov, Moreau, Gilbert, Sasseville, Duvic (bib15) 2014; 13
Schade, Schieven, Townsend (bib59) 2008; 111
Chakraborty, Robey, Luchenko (bib61) 2013; 121
Duvic (bib36) 2001; 7
Purnak, Azar, Mark (bib52) 2018; 31
Posner, Fossieck, Eddy, Bunn (bib24) 1981; 71
Fantin, Loboda, Paweletz (bib84) 2008; 68
Kuiper, Hogervorst, Herpers (bib40) 2021; 37
Borcherding, Voigt, Liu, Link, Zhang, Jabbari (bib65) 2019; 25
Brouet, Flandrin, Seligmann (bib2) 1973; 289
Bertolotto, Maulon, Filippa, Baier, Auberger (bib78) 2000; 275
Sors, Jean-Louis, Pellet (bib14) 2006; 107
38602696 - Blood. 2024 Apr 11;143(15):1436-1438
Mehindate (2024041115212284700_bib43) 1995; 182
Woetmann (2024041115212284700_bib68) 2007; 109
Willerslev-Olsen (2024041115212284700_bib26) 2013; 5
Buus (2024041115212284700_bib66) 2018; 2
Abraham (2024041115212284700_bib80) 2011; 12
Zinzani (2024041115212284700_bib53) 2007; 25
Willerslev-Olsen (2024041115212284700_bib71) 2016; 127
Bonin (2024041115212284700_bib25) 2010; 89
Kawai (2024041115212284700_bib62) 2007; 13
Huang (2024041115212284700_bib45) 2015; 125
Westergaard (2024041115212284700_bib54) 2020; 6
Girardi (2024041115212284700_bib5) 2004; 350
Pallesen (2024041115212284700_bib38) 2023; 143
Purnak (2024041115212284700_bib52) 2018; 31
Sorger (2024041115212284700_bib18) 2022; 14
Eichenseher (2024041115212284700_bib39) 2022; 66
Hammarén (2024041115212284700_bib63) 2019; 118
Bastidas Torres (2024041115212284700_bib8) 2018; 57
Willerslev-Olsen (2024041115212284700_bib69) 2021; 141
Lutzner (2024041115212284700_bib4) 1975; 83
Kim (2024041115212284700_bib6) 2003; 139
Sors (2024041115212284700_bib14) 2006; 107
2024041115212284700_bib50
Olsen (2024041115212284700_bib49) 2007; 25
Guenova (2024041115212284700_bib89) 2024; 144
Gluud (2024041115212284700_bib28) 2023; 141
Chakraborty (2024041115212284700_bib61) 2013; 121
Talpur (2024041115212284700_bib34) 2008; 159
Lu (2024041115212284700_bib83) 2015; 359
Fantin (2024041115212284700_bib73) 2007; 13
Song (2024041115212284700_bib10) 2022; 12
Allen (2024041115212284700_bib23) 2020; 61
Suga (2024041115212284700_bib30) 2014; 20
Duvic (2024041115212284700_bib36) 2001; 7
Brouet (2024041115212284700_bib2) 1973; 289
Bertolotto (2024041115212284700_bib78) 2000; 275
Zhang (2024041115212284700_bib21) 2022; 12
Chang (2024041115212284700_bib56) 2013; 3
Paul (2024041115212284700_bib57) 2013; 34
Tokura (2024041115212284700_bib81) 1992; 98
Tokura (2024041115212284700_bib32) 1995; 133
Wu (2024041115212284700_bib55) 2018; 154
Schade (2024041115212284700_bib59) 2008; 111
Meyer (2024041115212284700_bib64) 2010; 7
Chiao (2024041115212284700_bib74) 2002; 95
Emge (2024041115212284700_bib33) 2019; 81
Hooper (2024041115212284700_bib22) 2022; 2
Hurabielle (2024041115212284700_bib46) 2017; 23
Axelrod (2024041115212284700_bib19) 1992; 267
Weiner (2024041115212284700_bib12) 2021; 84
Abdin (2024041115212284700_bib75) 2021; 340
Borcherding (2024041115212284700_bib65) 2019; 25
Gaydosik (2024041115212284700_bib67) 2019; 25
Patel (2024041115212284700_bib13) 2020; 140
Jackow (2024041115212284700_bib31) 1997; 89
Fantin (2024041115212284700_bib84) 2008; 68
Tensen (2024041115212284700_bib11) 2022; 139
Thode (2024041115212284700_bib29) 2015; 135
Willerslev-Olsen (2024041115212284700_bib70) 2020; 10
Jones (2024041115212284700_bib48) 2001; 115
Posner (2024041115212284700_bib24) 1981; 71
Liu (2024041115212284700_bib88) 2024; 144
Krejsgaard (2024041115212284700_bib72) 2014; 124
McGirt (2024041115212284700_bib9) 2015; 126
Herrera (2024041115212284700_bib44) 2021; 138
Meley (2024041115212284700_bib77) 2010; 1
Mirvish (2024041115212284700_bib20) 2011; 64
Kuiper (2024041115212284700_bib40) 2021; 37
Vermeer (2024041115212284700_bib87) 2019; 134
Wollina (2024041115212284700_bib51) 2003; 98
Nielsen (2024041115212284700_bib17) 1997; 94
Vadivel (2024041115212284700_bib41) 2021; 13
Dummer (2024041115212284700_bib3) 2021; 7
Netchiporouk (2024041115212284700_bib15) 2014; 13
Buus (2024041115212284700_bib42) 2021; 10
Zhang (2024041115212284700_bib16) 1996; 93
Choi (2024041115212284700_bib7) 2015; 47
Cheng (2024041115212284700_bib79) 2011; 50
Cortes (2024041115212284700_bib85) 2021; 141
Butler (2024041115212284700_bib86) 2019; 139
Dehner (2024041115212284700_bib27) 2022; 2
Luchenko (2024041115212284700_bib37) 2014; 8
Lindahl (2024041115212284700_bib35) 2019; 134
Vonderheid (2024041115212284700_bib47) 2001; 117
Courtney (2024041115212284700_bib58) 2018; 43
2024041115212284700_bib60
Vonderheid (2024041115212284700_bib82) 2005; 152
Sézary (2024041115212284700_bib1) 1938; 45
Morotti (2024041115212284700_bib76) 2006; 81
References_xml – volume: 152
  start-page: 825
  year: 2005
  end-page: 826
  ident: bib82
  article-title: On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma
  publication-title: Br J Dermatol
  contributor:
    fullname: Hou
– volume: 13
  year: 2021
  ident: bib41
  article-title: JAK3 is expressed in the nucleus of malignant T cells in cutaneous T cell lymphoma (CTCL)
  publication-title: Cancers
  contributor:
    fullname: Torres-Rusillo
– volume: 139
  start-page: 857
  year: 2003
  end-page: 866
  ident: bib6
  article-title: Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome - clinical prognostic factors and risk for disease progression
  publication-title: Arch Dermatol
  contributor:
    fullname: Hoppe
– volume: 139
  start-page: 15
  year: 2022
  end-page: 33
  ident: bib11
  article-title: Genetic and epigenetic insights into cutaneous T-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Vermeer
– volume: 141
  start-page: 2908
  year: 2021
  end-page: 2920.e7
  ident: bib85
  article-title: Jak-STAT inhibition mediates romidepsin and mechlorethamine synergism in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Quinn
– volume: 124
  start-page: 761
  year: 2014
  end-page: 770
  ident: bib72
  article-title: Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
  publication-title: Blood
  contributor:
    fullname: Lindahl
– volume: 84
  start-page: 597
  year: 2021
  end-page: 604
  ident: bib12
  article-title: The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: current and future approaches
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Rook
– volume: 135
  start-page: 238
  year: 2015
  end-page: 246
  ident: bib29
  article-title: Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Wandall
– volume: 159
  start-page: 105
  year: 2008
  end-page: 112
  ident: bib34
  article-title: Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome
  publication-title: Br J Dermatol
  contributor:
    fullname: Duvic
– volume: 20
  start-page: 4339
  year: 2014
  end-page: 4348
  ident: bib30
  article-title: Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma
  publication-title: Clin Cancer Res
  contributor:
    fullname: Miyagaki
– volume: 13
  start-page: 460
  year: 2007
  end-page: 469
  ident: bib62
  article-title: Signaling to NF-kappaB by Toll-like receptors
  publication-title: Trends Mol Med
  contributor:
    fullname: Akira
– volume: 12
  year: 2022
  ident: bib21
  article-title: Alterations in the skin microbiota are associated with symptom severity in mycosis fungoides
  publication-title: Front Cell Infect Microbiol
  contributor:
    fullname: Cohen
– volume: 340
  year: 2021
  ident: bib75
  article-title: Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
  publication-title: Chem Biol Interact
  contributor:
    fullname: Omar
– volume: 64
  start-page: 423
  year: 2011
  end-page: 431
  ident: bib20
  article-title: Infectious agents in cutaneous T-cell lymphoma
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Geskin
– volume: 12
  start-page: 1019
  year: 2011
  end-page: 1022
  ident: bib80
  article-title: The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
  publication-title: Cancer Biol Ther
  contributor:
    fullname: Wasik
– volume: 7
  start-page: 61
  year: 2021
  ident: bib3
  article-title: Cutaneous T cell lymphoma
  publication-title: Nat Rev Dis Primers
  contributor:
    fullname: Scarisbrick
– volume: 12
  start-page: 1294
  year: 2022
  end-page: 1313
  ident: bib10
  article-title: Genomic and single-cell landscape reveals novel drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma
  publication-title: Cancer Discov
  contributor:
    fullname: Seminario-Vidal
– volume: 25
  start-page: 4293
  year: 2007
  end-page: 4297
  ident: bib53
  article-title: Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
  contributor:
    fullname: Tani
– volume: 98
  start-page: 33
  year: 1992
  end-page: 37
  ident: bib81
  article-title: Stimulation of cutaneous T-cell lymphoma-cells with superantigenic staphylococcal toxins
  publication-title: J Invest Dermatol
  contributor:
    fullname: Edelson
– volume: 13
  start-page: 7237
  year: 2007
  end-page: 7242
  ident: bib73
  article-title: Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications
  publication-title: Clin Cancer Res
  contributor:
    fullname: Richon
– volume: 13
  start-page: 3331
  year: 2014
  end-page: 3335
  ident: bib15
  article-title: Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
  publication-title: Cell Cycle
  contributor:
    fullname: Duvic
– volume: 25
  start-page: 3109
  year: 2007
  end-page: 3115
  ident: bib49
  article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
  contributor:
    fullname: Kuzel
– ident: bib60
  article-title: A dose finding study of AEB071 assessing psoriasis area and severity index in patients with plaque psoriasis. ClinicalTrials.gov identifier: NCT00885196
– volume: 14
  year: 2022
  ident: bib18
  article-title: Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma
  publication-title: EMBO Mol Med
  contributor:
    fullname: Vieyra-Garcia
– volume: 3
  start-page: 433
  year: 2013
  end-page: 445
  ident: bib56
  article-title: NFkappaB function and regulation in cutaneous T-cell lymphoma
  publication-title: Am J Cancer Res
  contributor:
    fullname: Vancurova
– volume: 118
  start-page: 48
  year: 2019
  end-page: 63
  ident: bib63
  article-title: The regulation of JAKs in cytokine signaling and its breakdown in disease
  publication-title: Cytokine
  contributor:
    fullname: Silvennoinen
– volume: 134
  start-page: 1000
  year: 2019
  end-page: 1001
  ident: bib87
  article-title: Antibiotics can improve CTCL
  publication-title: Blood
  contributor:
    fullname: Vermeer
– volume: 98
  start-page: 993
  year: 2003
  end-page: 1001
  ident: bib51
  article-title: Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma
  publication-title: Cancer
  contributor:
    fullname: Brockmeyer
– volume: 267
  start-page: 1354
  year: 1992
  end-page: 1358
  ident: bib19
  article-title: Infections complicating mycosis fungoides and Sézary syndrome
  publication-title: JAMA
  contributor:
    fullname: Vonderheid
– volume: 61
  start-page: 2652
  year: 2020
  end-page: 2658
  ident: bib23
  article-title: Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)
  publication-title: Leuk Lymphoma
  contributor:
    fullname: Lechowicz
– volume: 141
  start-page: 2449
  year: 2021
  end-page: 2458
  ident: bib69
  article-title: Staphylococcus aureus induces signal transducer and activator of transcription 5‒dependent miR-155 expression in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Lindahl
– ident: bib50
  article-title: Resminostat for maintenance treatment of patients with advanced stage mycosis fungoides (MF) or Sézary syndrome (SS). ClinicalTrials.gov identifier: NCT02953301
– volume: 7
  start-page: 41
  year: 2010
  ident: bib64
  article-title: Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
  publication-title: J Inflamm
  contributor:
    fullname: Li
– volume: 140
  start-page: 380
  year: 2020
  end-page: 389.e384
  ident: bib13
  article-title: Frequent and persistent PLCG1 mutations in Sézary cells directly enhance PLCgamma1 activity and stimulate NFkappaB, AP-1, and NFAT signaling
  publication-title: J Invest Dermatol
  contributor:
    fullname: Martins
– volume: 89
  start-page: 46
  year: 2010
  end-page: 50
  ident: bib25
  article-title: Evidence of multiple infectious agents in mycosis fungoides lesions
  publication-title: Exp Mol Pathol
  contributor:
    fullname: Trevisan
– volume: 117
  start-page: 654
  year: 2001
  end-page: 662
  ident: bib47
  article-title: Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome)
  publication-title: J Invest Dermatol
  contributor:
    fullname: Kotecha
– volume: 144
  start-page: 188
  year: 2024
  end-page: 191
  ident: bib88
  article-title: Characteristics of Staphylococcus aureus colonization in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Gao
– volume: 94
  start-page: 6764
  year: 1997
  end-page: 6769
  ident: bib17
  article-title: Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Nordahl
– volume: 43
  start-page: 108
  year: 2018
  end-page: 123
  ident: bib58
  article-title: TCR signaling: mechanisms of initiation and propagation
  publication-title: Trends Biochem Sci
  contributor:
    fullname: Weiss
– volume: 125
  start-page: 1435
  year: 2015
  end-page: 1443
  ident: bib45
  article-title: Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Zhou
– volume: 275
  start-page: 37246
  year: 2000
  end-page: 37250
  ident: bib78
  article-title: Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD
  publication-title: J Biol Chem
  contributor:
    fullname: Auberger
– volume: 107
  start-page: 2354
  year: 2006
  end-page: 2363
  ident: bib14
  article-title: Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
  publication-title: Blood
  contributor:
    fullname: Pellet
– volume: 109
  start-page: 3325
  year: 2007
  end-page: 3332
  ident: bib68
  article-title: Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
  publication-title: Blood
  contributor:
    fullname: Eriksen
– volume: 2
  year: 2022
  ident: bib27
  article-title: Malignant T cell activation by a Bacillus species isolated from cutaneous T-cell lymphoma lesions
  publication-title: JID Innov
  contributor:
    fullname: Greiling
– volume: 8
  start-page: 1379
  year: 2014
  end-page: 1392
  ident: bib37
  article-title: Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
  publication-title: Mol Oncol
  contributor:
    fullname: Chakraborty
– volume: 5
  start-page: 1402
  year: 2013
  end-page: 1421
  ident: bib26
  article-title: Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma
  publication-title: Toxins (Basel)
  contributor:
    fullname: Lindahl
– volume: 10
  year: 2021
  ident: bib42
  article-title: Improving oligo-conjugated antibody signal in multimodal single-cell analysis
  publication-title: Elife
  contributor:
    fullname: Ivanova
– volume: 350
  start-page: 1978
  year: 2004
  end-page: 1988
  ident: bib5
  article-title: The pathogenesis of mycosis fungoides
  publication-title: N Engl J Med
  contributor:
    fullname: Wilson
– volume: 47
  start-page: 1011
  year: 2015
  end-page: 1019
  ident: bib7
  article-title: Genomic landscape of cutaneous T cell lymphoma
  publication-title: Nat Genet
  contributor:
    fullname: Walradt
– volume: 66
  year: 2022
  ident: bib39
  article-title: Linker-improved chimeric endolysin selectively kills Staphylococcus aureus in vitro, on reconstituted human epidermis, and in a murine model of skin infection
  publication-title: Antimicrob Agents Chemother
  contributor:
    fullname: Badoux
– volume: 10
  start-page: 57
  year: 2020
  ident: bib70
  article-title: Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
  publication-title: Blood Cancer J
  contributor:
    fullname: Nastasi
– volume: 134
  start-page: 1072
  year: 2019
  end-page: 1083
  ident: bib35
  article-title: Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Gjerdrum
– volume: 144
  start-page: 8
  year: 2024
  end-page: 10
  ident: bib89
  article-title: Old sins cast long shadows: news on Staphylococcus aureus in cutaneous T cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Ødum
– volume: 89
  start-page: 32
  year: 1997
  end-page: 40
  ident: bib31
  article-title: Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion
  publication-title: Blood
  contributor:
    fullname: Duvic
– volume: 37
  start-page: 184
  year: 2021
  end-page: 193
  ident: bib40
  article-title: The novel endolysin XZ.700 effectively treats MRSA biofilms in two biofilm models without showing toxicity on human bone cells in vitro
  publication-title: Biofouling
  contributor:
    fullname: Herpers
– volume: 83
  start-page: 534
  year: 1975
  end-page: 552
  ident: bib4
  article-title: Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders
  publication-title: Ann Intern Med
  contributor:
    fullname: Ahmed
– volume: 25
  start-page: 4443
  year: 2019
  end-page: 4454
  ident: bib67
  article-title: Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors
  publication-title: Clin Cancer Res
  contributor:
    fullname: Geskin
– volume: 359
  start-page: 250
  year: 2015
  end-page: 258
  ident: bib83
  article-title: The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
  publication-title: Cancer Lett
  contributor:
    fullname: Feng
– volume: 143
  start-page: 1757
  year: 2023
  end-page: 1768.e3
  ident: bib38
  article-title: Endolysin inhibits skin colonization by patient-derived Staphylococcus aureus and malignant T cell activation in cutaneous T cell lymphoma
  publication-title: J Invest Dermatol
  contributor:
    fullname: Vadivel
– volume: 182
  start-page: 1573
  year: 1995
  end-page: 1577
  ident: bib43
  article-title: Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression
  publication-title: J Exp Med
  contributor:
    fullname: Mourad
– volume: 81
  start-page: 938
  year: 2006
  end-page: 945
  ident: bib76
  article-title: NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line
  publication-title: Am J Hematol
  contributor:
    fullname: Pautasso
– volume: 2
  year: 2022
  ident: bib22
  article-title: Nasal dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of non-Staphylococcus bacteria
  publication-title: JID Innov
  contributor:
    fullname: Veon
– volume: 139
  start-page: 1975
  year: 2019
  end-page: 1984.e2
  ident: bib86
  article-title: Contribution of STAT3 and RAD23B in primary Sézary cells to histone deacetylase inhibitor FK228 resistance
  publication-title: J Invest Dermatol
  contributor:
    fullname: Jones
– volume: 121
  start-page: 4115
  year: 2013
  end-page: 4125
  ident: bib61
  article-title: MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
  publication-title: Blood
  contributor:
    fullname: Luchenko
– volume: 154
  start-page: 1191
  year: 2018
  end-page: 1198
  ident: bib55
  article-title: Analysis of the effect of gentian violet on apoptosis and proliferation in cutaneous T-cell lymphoma in an in vitro study
  publication-title: JAMA Dermatol
  contributor:
    fullname: Wood
– volume: 6
  start-page: 761
  year: 2020
  end-page: 765
  ident: bib54
  article-title: Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab
  publication-title: JAAD Case Rep
  contributor:
    fullname: Khan
– volume: 126
  start-page: 508
  year: 2015
  end-page: 519
  ident: bib9
  article-title: Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides
  publication-title: Blood
  contributor:
    fullname: Baerenwald
– volume: 2
  start-page: 2115
  year: 2018
  end-page: 2126
  ident: bib66
  article-title: Single-cell heterogeneity in Sézary syndrome
  publication-title: Blood Adv
  contributor:
    fullname: Fredholm
– volume: 57
  start-page: 653
  year: 2018
  end-page: 664
  ident: bib8
  article-title: Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides
  publication-title: Genes Chromosomes Cancer
  contributor:
    fullname: Mei
– volume: 7
  start-page: 3
  year: 2001
  ident: bib36
  article-title: Current treatment of cutaneous T-cell lymphoma
  publication-title: Dermatol Online J
  contributor:
    fullname: Duvic
– volume: 115
  start-page: 885
  year: 2001
  end-page: 892
  ident: bib48
  article-title: Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood
  publication-title: Am J Clin Pathol
  contributor:
    fullname: Huh
– volume: 95
  start-page: 1696
  year: 2002
  end-page: 1705
  ident: bib74
  article-title: Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells
  publication-title: Cancer
  contributor:
    fullname: Curley
– volume: 133
  start-page: 6
  year: 1995
  end-page: 12
  ident: bib32
  article-title: Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens
  publication-title: Br J Dermatol
  contributor:
    fullname: Ohshima
– volume: 31
  start-page: e12586
  year: 2018
  ident: bib52
  article-title: Etoposide as a single agent in the treatment of mycosis fungoides: a retrospective analysis
  publication-title: Dermatol Ther
  contributor:
    fullname: Mark
– volume: 127
  start-page: 1287
  year: 2016
  end-page: 1296
  ident: bib71
  article-title: Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Lindahl
– volume: 1
  start-page: e41
  year: 2010
  ident: bib77
  article-title: p53-mediated delayed NF-kappaB activity enhances etoposide-induced cell death in medulloblastoma
  publication-title: Cell Death Dis
  contributor:
    fullname: See
– volume: 141
  start-page: 180
  year: 2023
  end-page: 193
  ident: bib28
  article-title: Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
  publication-title: Blood
  contributor:
    fullname: Buus
– volume: 93
  start-page: 9148
  year: 1996
  end-page: 9153
  ident: bib16
  article-title: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sézary syndrome
  publication-title: Proc Natl Acad Sci U S A
  contributor:
    fullname: Vonderheid
– volume: 45
  start-page: 254
  year: 1938
  end-page: 260
  ident: bib1
  article-title: Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant
  publication-title: Bull Soc Fr Dermatol Syphiligr
  contributor:
    fullname: Bouvrain
– volume: 138
  start-page: 1456
  year: 2021
  end-page: 1464
  ident: bib44
  article-title: Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures
  publication-title: Blood
  contributor:
    fullname: Mimitou
– volume: 50
  start-page: 113
  year: 2011
  end-page: 117
  ident: bib79
  article-title: Regulation of NF-kappaB induction by TCR/CD28
  publication-title: Immunol Res
  contributor:
    fullname: Kane
– volume: 111
  start-page: 1366
  year: 2008
  end-page: 1377
  ident: bib59
  article-title: Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
  publication-title: Blood
  contributor:
    fullname: Townsend
– volume: 25
  start-page: 2996
  year: 2019
  end-page: 3005
  ident: bib65
  article-title: Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression
  publication-title: Clin Cancer Res
  contributor:
    fullname: Jabbari
– volume: 289
  start-page: 341
  year: 1973
  end-page: 344
  ident: bib2
  article-title: Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome
  publication-title: N Engl J Med
  contributor:
    fullname: Seligmann
– volume: 81
  year: 2019
  ident: bib33
  article-title: Methicillin-resistant Staphylococcus aureus is an important pathogen in erythrodermic cutaneous T-cell lymphoma patients
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Huen
– volume: 23
  start-page: 3619
  year: 2017
  end-page: 3627
  ident: bib46
  article-title: Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with Sézary syndrome
  publication-title: Clin Cancer Res
  contributor:
    fullname: Ram-Wolff
– volume: 71
  start-page: 210
  year: 1981
  end-page: 216
  ident: bib24
  article-title: Septicemic complications of the cutaneous T-cell lymphomas
  publication-title: Am J Med
  contributor:
    fullname: Bunn
– volume: 34
  start-page: 269
  year: 2013
  end-page: 281
  ident: bib57
  article-title: A new look at T cell receptor signaling to nuclear factor-κB
  publication-title: Trends Immunol
  contributor:
    fullname: Schaefer
– volume: 68
  start-page: 3785
  year: 2008
  end-page: 3794
  ident: bib84
  article-title: Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma
  publication-title: Cancer Res
  contributor:
    fullname: Paweletz
– volume: 12
  start-page: 1294
  issue: 5
  year: 2022
  ident: 2024041115212284700_bib10
  article-title: Genomic and single-cell landscape reveals novel drivers and therapeutic vulnerabilities of transformed cutaneous T-cell lymphoma
  publication-title: Cancer Discov
  doi: 10.1158/2159-8290.CD-21-1207
  contributor:
    fullname: Song
– volume: 23
  start-page: 3619
  issue: 14
  year: 2017
  ident: 2024041115212284700_bib46
  article-title: Usefulness of KIR3DL2 to diagnose, follow-up, and manage the treatment of patients with Sézary syndrome
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-16-3185
  contributor:
    fullname: Hurabielle
– volume: 34
  start-page: 269
  issue: 6
  year: 2013
  ident: 2024041115212284700_bib57
  article-title: A new look at T cell receptor signaling to nuclear factor-κB
  publication-title: Trends Immunol
  doi: 10.1016/j.it.2013.02.002
  contributor:
    fullname: Paul
– volume: 89
  start-page: 32
  issue: 1
  year: 1997
  ident: 2024041115212284700_bib31
  article-title: Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion
  publication-title: Blood
  doi: 10.1182/blood.V89.1.32.32_32_40
  contributor:
    fullname: Jackow
– volume: 5
  start-page: 1402
  issue: 8
  year: 2013
  ident: 2024041115212284700_bib26
  article-title: Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma
  publication-title: Toxins (Basel)
  doi: 10.3390/toxins5081402
  contributor:
    fullname: Willerslev-Olsen
– volume: 10
  start-page: 57
  issue: 5
  year: 2020
  ident: 2024041115212284700_bib70
  article-title: Staphylococcus aureus enterotoxins induce FOXP3 in neoplastic T cells in Sézary syndrome
  publication-title: Blood Cancer J
  doi: 10.1038/s41408-020-0324-3
  contributor:
    fullname: Willerslev-Olsen
– volume: 118
  start-page: 48
  year: 2019
  ident: 2024041115212284700_bib63
  article-title: The regulation of JAKs in cytokine signaling and its breakdown in disease
  publication-title: Cytokine
  doi: 10.1016/j.cyto.2018.03.041
  contributor:
    fullname: Hammarén
– volume: 124
  start-page: 761
  issue: 5
  year: 2014
  ident: 2024041115212284700_bib72
  article-title: Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation
  publication-title: Blood
  doi: 10.1182/blood-2014-01-551184
  contributor:
    fullname: Krejsgaard
– volume: 109
  start-page: 3325
  issue: 8
  year: 2007
  ident: 2024041115212284700_bib68
  article-title: Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the presence of bacterial toxins
  publication-title: Blood
  doi: 10.1182/blood-2006-04-017863
  contributor:
    fullname: Woetmann
– volume: 152
  start-page: 825
  issue: 4
  year: 2005
  ident: 2024041115212284700_bib82
  article-title: On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2005.06524.x
  contributor:
    fullname: Vonderheid
– volume: 182
  start-page: 1573
  issue: 5
  year: 1995
  ident: 2024041115212284700_bib43
  article-title: Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression
  publication-title: J Exp Med
  doi: 10.1084/jem.182.5.1573
  contributor:
    fullname: Mehindate
– volume: 134
  start-page: 1000
  issue: 13
  year: 2019
  ident: 2024041115212284700_bib87
  article-title: Antibiotics can improve CTCL
  publication-title: Blood
  doi: 10.1182/blood.2019002236
  contributor:
    fullname: Vermeer
– volume: 144
  start-page: 188
  issue: 1
  year: 2024
  ident: 2024041115212284700_bib88
  article-title: Characteristics of Staphylococcus aureus colonization in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2023.06.205
  contributor:
    fullname: Liu
– volume: 143
  start-page: 1757
  issue: 9
  year: 2023
  ident: 2024041115212284700_bib38
  article-title: Endolysin inhibits skin colonization by patient-derived Staphylococcus aureus and malignant T cell activation in cutaneous T cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2023.01.039
  contributor:
    fullname: Pallesen
– volume: 68
  start-page: 3785
  issue: 10
  year: 2008
  ident: 2024041115212284700_bib84
  article-title: Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-6091
  contributor:
    fullname: Fantin
– volume: 139
  start-page: 1975
  issue: 9
  year: 2019
  ident: 2024041115212284700_bib86
  article-title: Contribution of STAT3 and RAD23B in primary Sézary cells to histone deacetylase inhibitor FK228 resistance
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2019.03.1130
  contributor:
    fullname: Butler
– volume: 289
  start-page: 341
  issue: 7
  year: 1973
  ident: 2024041115212284700_bib2
  article-title: Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJM197308162890703
  contributor:
    fullname: Brouet
– volume: 25
  start-page: 4443
  issue: 14
  year: 2019
  ident: 2024041115212284700_bib67
  article-title: Single-cell lymphocyte heterogeneity in advanced cutaneous T-cell lymphoma skin tumors
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-19-0148
  contributor:
    fullname: Gaydosik
– volume: 140
  start-page: 380
  issue: 2
  year: 2020
  ident: 2024041115212284700_bib13
  article-title: Frequent and persistent PLCG1 mutations in Sézary cells directly enhance PLCgamma1 activity and stimulate NFkappaB, AP-1, and NFAT signaling
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2019.07.693
  contributor:
    fullname: Patel
– volume: 7
  start-page: 41
  year: 2010
  ident: 2024041115212284700_bib64
  article-title: Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
  publication-title: J Inflamm
  contributor:
    fullname: Meyer
– volume: 139
  start-page: 15
  issue: 1
  year: 2022
  ident: 2024041115212284700_bib11
  article-title: Genetic and epigenetic insights into cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood.2019004256
  contributor:
    fullname: Tensen
– volume: 20
  start-page: 4339
  issue: 16
  year: 2014
  ident: 2024041115212284700_bib30
  article-title: Skin barrier dysfunction and low antimicrobial peptide expression in cutaneous T-cell lymphoma
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-14-0077
  contributor:
    fullname: Suga
– volume: 7
  start-page: 61
  issue: 1
  year: 2021
  ident: 2024041115212284700_bib3
  article-title: Cutaneous T cell lymphoma
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-021-00296-9
  contributor:
    fullname: Dummer
– volume: 37
  start-page: 184
  issue: 2
  year: 2021
  ident: 2024041115212284700_bib40
  article-title: The novel endolysin XZ.700 effectively treats MRSA biofilms in two biofilm models without showing toxicity on human bone cells in vitro
  publication-title: Biofouling
  doi: 10.1080/08927014.2021.1887151
  contributor:
    fullname: Kuiper
– volume: 25
  start-page: 3109
  issue: 21
  year: 2007
  ident: 2024041115212284700_bib49
  article-title: Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2006.10.2434
  contributor:
    fullname: Olsen
– volume: 71
  start-page: 210
  issue: 2
  year: 1981
  ident: 2024041115212284700_bib24
  article-title: Septicemic complications of the cutaneous T-cell lymphomas
  publication-title: Am J Med
  doi: 10.1016/0002-9343(81)90107-8
  contributor:
    fullname: Posner
– volume: 57
  start-page: 653
  issue: 12
  year: 2018
  ident: 2024041115212284700_bib8
  article-title: Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides
  publication-title: Genes Chromosomes Cancer
  doi: 10.1002/gcc.22679
  contributor:
    fullname: Bastidas Torres
– volume: 1
  start-page: e41
  issue: 5
  year: 2010
  ident: 2024041115212284700_bib77
  article-title: p53-mediated delayed NF-kappaB activity enhances etoposide-induced cell death in medulloblastoma
  publication-title: Cell Death Dis
  doi: 10.1038/cddis.2010.16
  contributor:
    fullname: Meley
– volume: 2
  start-page: 100132
  issue: 5
  year: 2022
  ident: 2024041115212284700_bib22
  article-title: Nasal dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of non-Staphylococcus bacteria
  publication-title: JID Innov
  doi: 10.1016/j.xjidi.2022.100132
  contributor:
    fullname: Hooper
– volume: 95
  start-page: 1696
  issue: 8
  year: 2002
  ident: 2024041115212284700_bib74
  article-title: Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells
  publication-title: Cancer
  doi: 10.1002/cncr.10829
  contributor:
    fullname: Chiao
– volume: 139
  start-page: 857
  issue: 7
  year: 2003
  ident: 2024041115212284700_bib6
  article-title: Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome - clinical prognostic factors and risk for disease progression
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.139.7.857
  contributor:
    fullname: Kim
– volume: 81
  start-page: 938
  issue: 12
  year: 2006
  ident: 2024041115212284700_bib76
  article-title: NF-kB inhibition as a strategy to enhance etoposide-induced apoptosis in K562 cell line
  publication-title: Am J Hematol
  doi: 10.1002/ajh.20732
  contributor:
    fullname: Morotti
– volume: 25
  start-page: 2996
  issue: 10
  year: 2019
  ident: 2024041115212284700_bib65
  article-title: Single-cell profiling of cutaneous T-cell lymphoma reveals underlying heterogeneity associated with disease progression
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-18-3309
  contributor:
    fullname: Borcherding
– ident: 2024041115212284700_bib60
– volume: 64
  start-page: 423
  issue: 2
  year: 2011
  ident: 2024041115212284700_bib20
  article-title: Infectious agents in cutaneous T-cell lymphoma
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2009.11.692
  contributor:
    fullname: Mirvish
– volume: 8
  start-page: 1379
  issue: 8
  year: 2014
  ident: 2024041115212284700_bib37
  article-title: Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2014.05.001
  contributor:
    fullname: Luchenko
– volume: 138
  start-page: 1456
  issue: 16
  year: 2021
  ident: 2024041115212284700_bib44
  article-title: Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures
  publication-title: Blood
  doi: 10.1182/blood.2020009346
  contributor:
    fullname: Herrera
– volume: 61
  start-page: 2652
  issue: 11
  year: 2020
  ident: 2024041115212284700_bib23
  article-title: Risk of bacteremia in patients with cutaneous T-cell lymphoma (CTCL)
  publication-title: Leuk Lymphoma
  doi: 10.1080/10428194.2020.1779259
  contributor:
    fullname: Allen
– volume: 13
  start-page: 3331
  issue: 21
  year: 2014
  ident: 2024041115212284700_bib15
  article-title: Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression
  publication-title: Cell Cycle
  doi: 10.4161/15384101.2014.965061
  contributor:
    fullname: Netchiporouk
– volume: 14
  start-page: e15200
  issue: 12
  year: 2022
  ident: 2024041115212284700_bib18
  article-title: Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T-cell lymphoma
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.202115200
  contributor:
    fullname: Sorger
– volume: 43
  start-page: 108
  issue: 2
  year: 2018
  ident: 2024041115212284700_bib58
  article-title: TCR signaling: mechanisms of initiation and propagation
  publication-title: Trends Biochem Sci
  doi: 10.1016/j.tibs.2017.11.008
  contributor:
    fullname: Courtney
– volume: 89
  start-page: 46
  issue: 1
  year: 2010
  ident: 2024041115212284700_bib25
  article-title: Evidence of multiple infectious agents in mycosis fungoides lesions
  publication-title: Exp Mol Pathol
  doi: 10.1016/j.yexmp.2010.05.001
  contributor:
    fullname: Bonin
– volume: 127
  start-page: 1287
  issue: 10
  year: 2016
  ident: 2024041115212284700_bib71
  article-title: Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2015-08-662353
  contributor:
    fullname: Willerslev-Olsen
– volume: 98
  start-page: 33
  issue: 1
  year: 1992
  ident: 2024041115212284700_bib81
  article-title: Stimulation of cutaneous T-cell lymphoma-cells with superantigenic staphylococcal toxins
  publication-title: J Invest Dermatol
  doi: 10.1111/1523-1747.ep12494184
  contributor:
    fullname: Tokura
– volume: 141
  start-page: 2908
  issue: 12
  year: 2021
  ident: 2024041115212284700_bib85
  article-title: Jak-STAT inhibition mediates romidepsin and mechlorethamine synergism in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2021.04.023
  contributor:
    fullname: Cortes
– volume: 107
  start-page: 2354
  issue: 6
  year: 2006
  ident: 2024041115212284700_bib14
  article-title: Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis
  publication-title: Blood
  doi: 10.1182/blood-2005-06-2536
  contributor:
    fullname: Sors
– volume: 125
  start-page: 1435
  issue: 9
  year: 2015
  ident: 2024041115212284700_bib45
  article-title: Evidence of an oncogenic role of aberrant TOX activation in cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood-2014-05-571778
  contributor:
    fullname: Huang
– volume: 13
  start-page: 7237
  issue: 24
  year: 2007
  ident: 2024041115212284700_bib73
  article-title: Mechanisms of resistance to histone deacetylase inhibitors and their therapeutic implications
  publication-title: Clin Cancer Res
  doi: 10.1158/1078-0432.CCR-07-2114
  contributor:
    fullname: Fantin
– volume: 159
  start-page: 105
  issue: 1
  year: 2008
  ident: 2024041115212284700_bib34
  article-title: Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2008.08612.x
  contributor:
    fullname: Talpur
– volume: 117
  start-page: 654
  issue: 3
  year: 2001
  ident: 2024041115212284700_bib47
  article-title: Variable CD7 expression on T cells in the leukemic phase of cutaneous T cell lymphoma (Sézary syndrome)
  publication-title: J Invest Dermatol
  doi: 10.1046/j.1523-1747.2001.01456.x
  contributor:
    fullname: Vonderheid
– volume: 13
  start-page: 280
  issue: 2
  year: 2021
  ident: 2024041115212284700_bib41
  article-title: JAK3 is expressed in the nucleus of malignant T cells in cutaneous T cell lymphoma (CTCL)
  publication-title: Cancers
  doi: 10.3390/cancers13020280
  contributor:
    fullname: Vadivel
– volume: 31
  start-page: e12586
  issue: 2
  year: 2018
  ident: 2024041115212284700_bib52
  article-title: Etoposide as a single agent in the treatment of mycosis fungoides: a retrospective analysis
  publication-title: Dermatol Ther
  doi: 10.1111/dth.12586
  contributor:
    fullname: Purnak
– volume: 47
  start-page: 1011
  issue: 9
  year: 2015
  ident: 2024041115212284700_bib7
  article-title: Genomic landscape of cutaneous T cell lymphoma
  publication-title: Nat Genet
  doi: 10.1038/ng.3356
  contributor:
    fullname: Choi
– volume: 126
  start-page: 508
  issue: 4
  year: 2015
  ident: 2024041115212284700_bib9
  article-title: Whole-genome sequencing reveals oncogenic mutations in mycosis fungoides
  publication-title: Blood
  doi: 10.1182/blood-2014-11-611194
  contributor:
    fullname: McGirt
– volume: 154
  start-page: 1191
  issue: 10
  year: 2018
  ident: 2024041115212284700_bib55
  article-title: Analysis of the effect of gentian violet on apoptosis and proliferation in cutaneous T-cell lymphoma in an in vitro study
  publication-title: JAMA Dermatol
  doi: 10.1001/jamadermatol.2018.2756
  contributor:
    fullname: Wu
– volume: 13
  start-page: 460
  issue: 11
  year: 2007
  ident: 2024041115212284700_bib62
  article-title: Signaling to NF-kappaB by Toll-like receptors
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2007.09.002
  contributor:
    fullname: Kawai
– volume: 359
  start-page: 250
  issue: 2
  year: 2015
  ident: 2024041115212284700_bib83
  article-title: The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2015.01.021
  contributor:
    fullname: Lu
– volume: 2
  start-page: 100084
  issue: 2
  year: 2022
  ident: 2024041115212284700_bib27
  article-title: Malignant T cell activation by a Bacillus species isolated from cutaneous T-cell lymphoma lesions
  publication-title: JID Innov
  doi: 10.1016/j.xjidi.2021.100084
  contributor:
    fullname: Dehner
– volume: 134
  start-page: 1072
  issue: 13
  year: 2019
  ident: 2024041115212284700_bib35
  article-title: Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood.2018888107
  contributor:
    fullname: Lindahl
– volume: 93
  start-page: 9148
  issue: 17
  year: 1996
  ident: 2024041115212284700_bib16
  article-title: Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sézary syndrome
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.17.9148
  contributor:
    fullname: Zhang
– volume: 7
  start-page: 3
  issue: 1
  year: 2001
  ident: 2024041115212284700_bib36
  article-title: Current treatment of cutaneous T-cell lymphoma
  publication-title: Dermatol Online J
  doi: 10.5070/D33BS957XS
  contributor:
    fullname: Duvic
– volume: 111
  start-page: 1366
  issue: 3
  year: 2008
  ident: 2024041115212284700_bib59
  article-title: Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation
  publication-title: Blood
  doi: 10.1182/blood-2007-04-084814
  contributor:
    fullname: Schade
– ident: 2024041115212284700_bib50
– volume: 83
  start-page: 534
  issue: 4
  year: 1975
  ident: 2024041115212284700_bib4
  article-title: Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-83-4-534
  contributor:
    fullname: Lutzner
– volume: 141
  start-page: 180
  issue: 2
  year: 2023
  ident: 2024041115212284700_bib28
  article-title: Malignant T cells induce skin barrier defects through cytokine-mediated JAK/STAT signaling in cutaneous T-cell lymphoma
  publication-title: Blood
  doi: 10.1182/blood.2022016690
  contributor:
    fullname: Gluud
– volume: 10
  start-page: e61973
  year: 2021
  ident: 2024041115212284700_bib42
  article-title: Improving oligo-conjugated antibody signal in multimodal single-cell analysis
  publication-title: Elife
  doi: 10.7554/eLife.61973
  contributor:
    fullname: Buus
– volume: 6
  start-page: 761
  issue: 8
  year: 2020
  ident: 2024041115212284700_bib54
  article-title: Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab
  publication-title: JAAD Case Rep
  doi: 10.1016/j.jdcr.2020.05.035
  contributor:
    fullname: Westergaard
– volume: 340
  start-page: 109450
  year: 2021
  ident: 2024041115212284700_bib75
  article-title: Nuclear factor-κB signaling inhibitors revert multidrug-resistance in breast cancer cells
  publication-title: Chem Biol Interact
  doi: 10.1016/j.cbi.2021.109450
  contributor:
    fullname: Abdin
– volume: 98
  start-page: 993
  issue: 5
  year: 2003
  ident: 2024041115212284700_bib51
  article-title: Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T-cell lymphoma
  publication-title: Cancer
  doi: 10.1002/cncr.11593
  contributor:
    fullname: Wollina
– volume: 45
  start-page: 254
  year: 1938
  ident: 2024041115212284700_bib1
  article-title: Erythrodermie avec présence de cellules monstrueuses dans le derme et le sang circulant
  publication-title: Bull Soc Fr Dermatol Syphiligr
  contributor:
    fullname: Sézary
– volume: 350
  start-page: 1978
  issue: 19
  year: 2004
  ident: 2024041115212284700_bib5
  article-title: The pathogenesis of mycosis fungoides
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra032810
  contributor:
    fullname: Girardi
– volume: 66
  start-page: e0227321
  issue: 5
  year: 2022
  ident: 2024041115212284700_bib39
  article-title: Linker-improved chimeric endolysin selectively kills Staphylococcus aureus in vitro, on reconstituted human epidermis, and in a murine model of skin infection
  publication-title: Antimicrob Agents Chemother
  doi: 10.1128/aac.02273-21
  contributor:
    fullname: Eichenseher
– volume: 12
  start-page: 1019
  issue: 12
  year: 2011
  ident: 2024041115212284700_bib80
  article-title: The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma
  publication-title: Cancer Biol Ther
  doi: 10.4161/cbt.12.12.18144
  contributor:
    fullname: Abraham
– volume: 12
  start-page: 850509
  year: 2022
  ident: 2024041115212284700_bib21
  article-title: Alterations in the skin microbiota are associated with symptom severity in mycosis fungoides
  publication-title: Front Cell Infect Microbiol
  doi: 10.3389/fcimb.2022.850509
  contributor:
    fullname: Zhang
– volume: 133
  start-page: 6
  issue: 1
  year: 1995
  ident: 2024041115212284700_bib32
  article-title: Cutaneous colonization with staphylococci influences the disease activity of Sézary syndrome: a potential role for bacterial superantigens
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.1995.tb02485.x
  contributor:
    fullname: Tokura
– volume: 2
  start-page: 2115
  issue: 16
  year: 2018
  ident: 2024041115212284700_bib66
  article-title: Single-cell heterogeneity in Sézary syndrome
  publication-title: Blood Adv
  doi: 10.1182/bloodadvances.2018022608
  contributor:
    fullname: Buus
– volume: 25
  start-page: 4293
  issue: 27
  year: 2007
  ident: 2024041115212284700_bib53
  article-title: Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2007.11.4207
  contributor:
    fullname: Zinzani
– volume: 3
  start-page: 433
  issue: 5
  year: 2013
  ident: 2024041115212284700_bib56
  article-title: NFkappaB function and regulation in cutaneous T-cell lymphoma
  publication-title: Am J Cancer Res
  contributor:
    fullname: Chang
– volume: 267
  start-page: 1354
  issue: 10
  year: 1992
  ident: 2024041115212284700_bib19
  article-title: Infections complicating mycosis fungoides and Sézary syndrome
  publication-title: JAMA
  doi: 10.1001/jama.1992.03480100060031
  contributor:
    fullname: Axelrod
– volume: 94
  start-page: 6764
  issue: 13
  year: 1997
  ident: 2024041115212284700_bib17
  article-title: Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: Tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.94.13.6764
  contributor:
    fullname: Nielsen
– volume: 275
  start-page: 37246
  issue: 47
  year: 2000
  ident: 2024041115212284700_bib78
  article-title: Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M007732200
  contributor:
    fullname: Bertolotto
– volume: 141
  start-page: 2449
  issue: 10
  year: 2021
  ident: 2024041115212284700_bib69
  article-title: Staphylococcus aureus induces signal transducer and activator of transcription 5‒dependent miR-155 expression in cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2021.01.038
  contributor:
    fullname: Willerslev-Olsen
– volume: 121
  start-page: 4115
  issue: 20
  year: 2013
  ident: 2024041115212284700_bib61
  article-title: MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor
  publication-title: Blood
  doi: 10.1182/blood-2012-08-449140
  contributor:
    fullname: Chakraborty
– volume: 84
  start-page: 597
  issue: 3
  year: 2021
  ident: 2024041115212284700_bib12
  article-title: The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: current and future approaches
  publication-title: J Am Acad Dermatol
  doi: 10.1016/j.jaad.2020.12.026
  contributor:
    fullname: Weiner
– volume: 50
  start-page: 113
  issue: 2-3
  year: 2011
  ident: 2024041115212284700_bib79
  article-title: Regulation of NF-kappaB induction by TCR/CD28
  publication-title: Immunol Res
  doi: 10.1007/s12026-011-8216-z
  contributor:
    fullname: Cheng
– volume: 135
  start-page: 238
  issue: 1
  year: 2015
  ident: 2024041115212284700_bib29
  article-title: Malignant T cells secrete galectins and induce epidermal hyperproliferation and disorganized stratification in a skin model of cutaneous T-cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2014.284
  contributor:
    fullname: Thode
– volume: 81
  issue: 4
  year: 2019
  ident: 2024041115212284700_bib33
  article-title: Methicillin-resistant Staphylococcus aureus is an important pathogen in erythrodermic cutaneous T-cell lymphoma patients
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Emge
– volume: 115
  start-page: 885
  issue: 6
  year: 2001
  ident: 2024041115212284700_bib48
  article-title: Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood
  publication-title: Am J Clin Pathol
  doi: 10.1309/U1Y6-J4AG-5M4M-7AYV
  contributor:
    fullname: Jones
– volume: 144
  start-page: 8
  issue: 1
  year: 2024
  ident: 2024041115212284700_bib89
  article-title: Old sins cast long shadows: news on Staphylococcus aureus in cutaneous T cell lymphoma
  publication-title: J Invest Dermatol
  doi: 10.1016/j.jid.2023.08.031
  contributor:
    fullname: Guenova
SSID ssj0014325
Score 2.5315676
Snippet •Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS.•Targeting bacteria, their toxins, and downstream signaling...
Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a poor...
Abstract Patients with Sézary syndrome (SS), a leukemic variant of cutaneous T-cell lymphoma (CTCL), are prone to Staphylococcus aureus infections and have a...
• Enterotoxins from S aureus bacteria induce drug resistance in primary malignant T cells in SS. • Targeting bacteria, their toxins, and downstream signaling...
SourceID pubmedcentral
proquest
crossref
pubmed
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 1496
SubjectTerms Lymphoid Neoplasia
Title Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
URI https://dx.doi.org/10.1182/blood.2023021671
https://www.ncbi.nlm.nih.gov/pubmed/38170178
https://www.proquest.com/docview/2910189225
https://pubmed.ncbi.nlm.nih.gov/PMC11033614
Volume 143
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLaqIcZeEHRcyk1GYkioSkmcS5PHrgJNQxuXZdLESxQ7DqvUpVPbILFfwyv_gGf4Y5xjx0k6CoK9RKnb1InPl-Pv2OdCyDNbhkMW-rmVD4Pc8pgEPQgTkcV4AIaYTIECKC_fw2Dv2Ns_8U86ne8tr6VyyQfiYm1cyVWkCm0gV4yS_Q_J1n8KDXAO8oUjSBiO_yRjYIowSjAdzYQoF_20nMsS_auyEv2ssnn5qQ_WNDJEfH0nxc6Y7YxsgZ_m_biPi_bKHfZIb5dfoAfduhQGu9OqpLwuzZWBhpzqvXr0nVKK4rRo9LsKL1xM5Wfr7bRa4FF-k2nN3w9TTGlSxQot4Q4-DPr7g3oRW2oF9HGSztqrEkw5szjNqkTchMUUtf8p7kxgItpmv8Ao5QAL3emrZaWHMXG2zewVRa0TOhlE-i29C3Ze0JrDkcasnx9CzDerYgIGWDgeGE6gO27B5fxM4UXlLnR0gaHVRN3vDsbAmlw3wArq1xioONStb943-1eey3TtjOrRzAZ5yF5e7nyLbJqe_sSNfrd9LrvwtjhRfIvcrIwZOtLIvE06suiS7VEBg3_2hT6nyr1YyaFLru-asxtjU2SwSzYPKt-ObRKvoplqNNMKzRTRTBs0Q_uPrxrJNKYKydBEj35-QxRTg-I75Pj1q3i8Z1U1PyzheeHS4iIIWARWSsRxyz11MiRZIkptwYFry8gRjiscD-ugYVS49IFPpT6PhJtlee66d8lGMSvkfUJFKIaMe5geKvOGXKTBMJeZm9o551ngZz3ywox2cq5TuyTKJA5ZooSUNELqEdeII6moqaacCSDrL1c9NZJLYFxxLNJCzspFAo9oO2EEk2mP3NOSrO_BoKFHwhUZ1z_AjPCr3xSTU5UZ3qDywdUvfUi2mvf5EdlYzkv5GHj3kj9REP8FCsTaAw
link.rule.ids 230,315,783,787,888,27936,27937
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Staphylococcus+aureus+induces+drug+resistance+in%C2%A0cancer+T+cells+in+S%C3%A9zary+syndrome&rft.jtitle=Blood&rft.au=Vadivel%2C+Chella+Krishna&rft.au=Willerslev-Olsen%2C+Andreas&rft.au=Namini%2C+Martin+R.+J.&rft.au=Zeng%2C+Ziao&rft.date=2024-04-11&rft.pub=The+American+Society+of+Hematology&rft.issn=0006-4971&rft.eissn=1528-0020&rft.volume=143&rft.issue=15&rft.spage=1496&rft.epage=1512&rft_id=info:doi/10.1182%2Fblood.2023021671&rft_id=info%3Apmid%2F38170178&rft.externalDBID=PMC11033614
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-4971&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-4971&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-4971&client=summon